Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 – New England Journal of Medicine Audio Interview: A New Antiviral against Covid-19 – new England Journal of Medicine Related: [Press release – not published yet] Pfizer’s Covid pill remains 89% effective for reducing the risk of hospitalization or death in final analysis. [Press release – not […]

The post RCT: Oral Nirmatrelvir for high-risk adults with Covid-19 reduces the risk of hospitalization by 89%. appeared first on Links Medicus.